Literature DB >> 10506577

Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls.

N Miosge1, T Sasaki, R Timpl.   

Abstract

Theendothelial cell inhibitor endostatin (22 kDa) is part of the carboxyl-terminal globular domain of collagen XVIII and shows a widespread tissue distribution. Immunohistology of adult mouse tissues demonstrated a preferred localization in many vessel walls and some other basement membrane zones. A strong immunogold staining was observed across elastic fibers in the multiple elastic membranes of aorta and other large arteries. Staining was less strong along sparse elastic fibers of veins and almost none was observed in the walls of arterioles and capillaries. Strong evidence was also obtained for some intracellular and basement membrane associations. Immunogold double staining of elastic fibers showed a close colocalization of endostatin with fibulin-2, fibulin-1, and nidogen-2, but not with perlecan. Reasonable amounts of endostatin could be extracted from aorta and skin by EDTA, followed by detergents, with aorta being the richest source of the inhibitor identified so far. Solubilizations with collagenase and elastase were approximately fivefold less efficient. Immunoblots of aortic extracts detected major endostatin components of 22-25 kDa whereas skin extracts also contained some larger components. Solid-phase assays demonstrated distinct binding of recombinant mouse endostatin to the fibulins and nidogen-2, consistent with their tissue colocalization. Together, the data indicate several different ways for endostatin to be associated with the extracellular matrix, and its release may determine biological activation. This also defines a novel function for some elastic tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506577     DOI: 10.1096/fasebj.13.13.1743

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  23 in total

Review 1.  New functional roles for non-collagenous domains of basement membrane collagens.

Authors:  Nathalie Ortega; Zena Werb
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

Review 2.  Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix.

Authors:  C M Kielty; T J Wess; L Haston; Jane L Ashworth; M J Sherratt; C A Shuttleworth
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

3.  Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity.

Authors:  Ming Yi; Takao Sakai; Reinhard Fassler; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

4.  Structural and functional characterization of the human and mouse fibulin-1 gene promoters: role of Sp1 and Sp3.

Authors:  Mirco Castoldi; Mon-Li Chu
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

Review 5.  Molecular mechanisms of tumor angiogenesis and tumor progression.

Authors:  U Cavallaro; G Christofori
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

6.  Serum endostatin and bFGF as predictive factors in advanced breast cancer patients treated with letrozole.

Authors:  Emilio Alba; Antonio Llombart; Nuria Ribelles; Manuel Ramos; Roberto Fernández; José Ignacio Mayordomo; Ignasi Tusquets; Miguel Gil; Agustí Barnadas; Francisco Carabante; Manuel Ruiz; Ruth Vera; Isabel Palomero; Vicente Soriano; Jesús González; Ramón Colomer
Journal:  Clin Transl Oncol       Date:  2006-03       Impact factor: 3.405

7.  The changes in various hydroxyproline fractions in aortic tissue of rabbits are closely related to the progression of atherosclerosis.

Authors:  Mohamed Anwar K Abdelhalim; N J Siddiqi; A S Alhomida; Mohammed S Al-Ayed
Journal:  Lipids Health Dis       Date:  2010-03-09       Impact factor: 3.876

8.  Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice.

Authors:  Qing Li; Bjorn R Olsen
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

9.  E-selectin is required for the antiangiogenic activity of endostatin.

Authors:  Ying Yu; Karen S Moulton; Mohamed K Khan; Sabrina Vineberg; Eileen Boye; Vannessa M Davis; Peter E O'Donnell; Joyce Bischoff; David S Milstone
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

10.  Loss of fibulin-2 expression is associated with breast cancer progression.

Authors:  Chun-Hui Yi; David J Smith; William W West; Michael A Hollingsworth
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.